Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Marilyn Manco-Johnson

Concepts (497)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
55
2026
147
11.760
 Why?
Factor VIII
35
2024
105
5.840
 Why?
Hemophilia B
14
2026
65
3.360
 Why?
Hemarthrosis
10
2020
22
3.160
 Why?
Protein C
18
2025
53
3.100
 Why?
Venous Thrombosis
14
2024
193
2.560
 Why?
Hemorrhage
27
2024
813
2.520
 Why?
Protein C Deficiency
10
2025
11
2.180
 Why?
Anticoagulants
19
2024
729
2.050
 Why?
Thrombosis
24
2024
396
2.020
 Why?
Joints
7
2026
107
1.970
 Why?
Thrombophilia
16
2022
89
1.920
 Why?
Hemostasis
7
2023
98
1.850
 Why?
Venous Thromboembolism
15
2024
326
1.830
 Why?
Factor IX
9
2016
49
1.630
 Why?
Thromboembolism
11
2016
126
1.610
 Why?
Child, Preschool
85
2026
11790
1.570
 Why?
Child
114
2026
22600
1.560
 Why?
Blood Coagulation
14
2024
268
1.520
 Why?
Infant
75
2026
10023
1.460
 Why?
Coagulants
7
2018
19
1.430
 Why?
Adolescent
94
2026
22409
1.370
 Why?
Postthrombotic Syndrome
4
2024
13
1.370
 Why?
Fibrinogen
8
2024
181
1.270
 Why?
Hemostatics
3
2022
60
1.250
 Why?
Fibrinolysis
6
2013
164
1.190
 Why?
von Willebrand Factor
6
2023
85
1.170
 Why?
Blood Coagulation Tests
13
2016
69
1.110
 Why?
Fibrinolytic Agents
12
2024
290
1.090
 Why?
Afibrinogenemia
5
2024
8
1.020
 Why?
Young Adult
42
2026
14122
0.940
 Why?
Pulmonary Embolism
7
2024
241
0.930
 Why?
Thrombolytic Therapy
6
2024
161
0.930
 Why?
Infant, Newborn
42
2024
6399
0.900
 Why?
Humans
165
2026
144667
0.890
 Why?
Male
99
2026
72431
0.760
 Why?
Antithrombin III Deficiency
4
2021
8
0.740
 Why?
Prospective Studies
28
2025
7994
0.740
 Why?
Joint Diseases
5
2019
61
0.740
 Why?
Blood Coagulation Disorders
5
2021
196
0.720
 Why?
Adult
57
2026
40489
0.710
 Why?
Pregnancy Complications, Hematologic
6
2024
24
0.700
 Why?
Quality of Life
8
2022
3183
0.680
 Why?
Antithrombins
4
2021
69
0.680
 Why?
Pain Measurement
2
2021
554
0.670
 Why?
von Willebrand Disease, Type 1
3
2017
5
0.660
 Why?
Treatment Outcome
28
2025
11735
0.660
 Why?
Factor V
7
2019
26
0.640
 Why?
Female
89
2026
78304
0.630
 Why?
Pain
2
2021
785
0.600
 Why?
Hemorrhagic Disorders
2
2018
10
0.590
 Why?
Registries
8
2025
2392
0.580
 Why?
Severity of Illness Index
10
2026
2922
0.560
 Why?
Purpura Fulminans
2
2016
2
0.550
 Why?
Blood Platelets
5
2025
379
0.550
 Why?
Drug Administration Schedule
9
2024
779
0.540
 Why?
Disseminated Intravascular Coagulation
6
2020
33
0.520
 Why?
Stroke
7
2018
1262
0.520
 Why?
Thrombin
3
2023
167
0.520
 Why?
Catheterization, Central Venous
5
2007
124
0.510
 Why?
Antiphospholipid Syndrome
5
2012
37
0.510
 Why?
Fetus
3
2023
800
0.500
 Why?
Age Factors
13
2024
3329
0.490
 Why?
Tissue Plasminogen Activator
3
2011
244
0.490
 Why?
Primary Prevention
2
2020
217
0.470
 Why?
Surveys and Questionnaires
7
2021
6041
0.470
 Why?
Blood Coagulation Factors
7
2006
60
0.460
 Why?
Risk Factors
26
2025
10796
0.440
 Why?
Case-Control Studies
12
2024
3603
0.430
 Why?
Population Surveillance
1
2018
484
0.430
 Why?
von Willebrand Diseases
2
2011
28
0.420
 Why?
Middle Aged
28
2026
35971
0.420
 Why?
Cerebral Arterial Diseases
5
2016
49
0.400
 Why?
Hyperhomocysteinemia
1
2013
27
0.390
 Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2013
35
0.390
 Why?
Isoantibodies
5
2016
57
0.390
 Why?
Heparin
7
2005
243
0.390
 Why?
Apoprotein(a)
1
2013
8
0.390
 Why?
Sucrose
1
2013
114
0.370
 Why?
Half-Life
3
2022
152
0.370
 Why?
Lipoprotein(a)
1
2013
69
0.360
 Why?
Brain Ischemia
5
2016
358
0.340
 Why?
Point Mutation
5
2008
242
0.340
 Why?
Blood Component Transfusion
3
2010
104
0.340
 Why?
Fibrinolysin
1
2011
19
0.330
 Why?
Aged
18
2026
25955
0.320
 Why?
Pregnancy
14
2024
7122
0.320
 Why?
Blood Loss, Surgical
1
2011
110
0.320
 Why?
United States
18
2025
16018
0.320
 Why?
Asphyxia Neonatorum
1
2010
21
0.310
 Why?
Range of Motion, Articular
3
2024
423
0.300
 Why?
Lupus Coagulation Inhibitor
3
1999
6
0.300
 Why?
Biomarkers
8
2020
4261
0.300
 Why?
Reproducibility of Results
9
2021
3414
0.300
 Why?
Elective Surgical Procedures
1
2011
201
0.300
 Why?
Colorado
12
2019
4558
0.300
 Why?
Fibrin
3
2022
84
0.290
 Why?
Time Factors
9
2025
7140
0.290
 Why?
Platelet Aggregation
3
2018
98
0.290
 Why?
Psychometrics
2
2019
731
0.290
 Why?
Antibodies, Antiphospholipid
3
2011
29
0.290
 Why?
Chickenpox
2
2001
80
0.270
 Why?
Embolization, Therapeutic
1
2011
241
0.270
 Why?
Physical Examination
2
2007
240
0.270
 Why?
Patient Satisfaction
2
2017
707
0.270
 Why?
Antibodies, Neutralizing
3
2016
341
0.270
 Why?
Fibrin Fibrinogen Degradation Products
5
2012
92
0.270
 Why?
Sheep
5
2008
880
0.260
 Why?
Postphlebitic Syndrome
1
2007
3
0.260
 Why?
Protein S
5
2002
10
0.250
 Why?
Equipment Contamination
1
2007
71
0.250
 Why?
Models, Animal
1
2008
393
0.250
 Why?
Sports
1
2009
215
0.250
 Why?
Cross-Sectional Studies
8
2026
5870
0.250
 Why?
Developmental Disabilities
1
2010
279
0.250
 Why?
Europe
2
2025
419
0.240
 Why?
Varicose Ulcer
1
2006
5
0.240
 Why?
Tumor Necrosis Factor-alpha
2
2025
1207
0.230
 Why?
Catheters, Indwelling
3
2005
97
0.230
 Why?
Infection Control
1
2007
174
0.230
 Why?
Recombinant Proteins
5
2015
1363
0.230
 Why?
Qa-SNARE Proteins
1
2025
18
0.230
 Why?
Bacteria, Anaerobic
1
2005
25
0.230
 Why?
Jugular Veins
1
2005
42
0.230
 Why?
Cognition Disorders
1
2010
539
0.230
 Why?
Thrombelastography
4
2018
190
0.220
 Why?
Recurrence
10
2024
1136
0.220
 Why?
Microfluidic Analytical Techniques
2
2017
79
0.220
 Why?
Down-Regulation
2
2025
616
0.220
 Why?
Sepsis
4
2020
643
0.220
 Why?
Ibuprofen
1
2005
84
0.210
 Why?
Brain Injuries
1
2010
506
0.210
 Why?
Hematology
1
2024
21
0.210
 Why?
Knee Joint
2
2024
426
0.210
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2018
338
0.210
 Why?
Health Care Surveys
1
2006
537
0.210
 Why?
Plasma
1
2006
223
0.200
 Why?
Incidence
9
2022
2892
0.200
 Why?
Prothrombin
6
2008
24
0.200
 Why?
Infusions, Intravenous
4
2018
422
0.200
 Why?
Amino Acid Substitution
3
2001
303
0.200
 Why?
Thrombectomy
1
2024
78
0.200
 Why?
Prevalence
8
2016
2839
0.200
 Why?
Bacterial Infections
1
2005
247
0.190
 Why?
Phenotype
6
2021
3147
0.190
 Why?
Follow-Up Studies
10
2022
5414
0.190
 Why?
Autoantibodies
2
2001
1505
0.190
 Why?
Autophagy
1
2025
284
0.190
 Why?
Placenta
2
2023
781
0.180
 Why?
Athletic Injuries
1
2009
571
0.180
 Why?
Synovitis
1
2002
33
0.180
 Why?
Mutation
10
2015
4081
0.180
 Why?
Clinical Trials as Topic
5
2010
1056
0.180
 Why?
Fetal Blood
4
2014
325
0.180
 Why?
Partial Thromboplastin Time
3
1999
52
0.180
 Why?
Blood Proteins
3
2001
230
0.170
 Why?
Administration, Oral
1
2024
851
0.170
 Why?
Intracranial Hemorrhages
2
2024
101
0.170
 Why?
Warfarin
4
2012
173
0.170
 Why?
Medical Oncology
1
2024
331
0.170
 Why?
Quality of Health Care
1
2006
692
0.160
 Why?
Cohort Studies
13
2020
5957
0.160
 Why?
Diagnostic Techniques and Procedures
1
2000
19
0.160
 Why?
Heparin Lyase
1
2000
5
0.160
 Why?
Patient Compliance
2
2003
587
0.160
 Why?
Premedication
1
2020
44
0.160
 Why?
Nigeria
1
2020
24
0.160
 Why?
Thrombophlebitis
2
1997
12
0.160
 Why?
Prognosis
7
2020
4312
0.160
 Why?
Blood Specimen Collection
1
2000
37
0.160
 Why?
Neoplasm Proteins
2
2013
441
0.160
 Why?
Platelet Function Tests
2
2017
35
0.160
 Why?
Fellowships and Scholarships
1
2024
355
0.160
 Why?
North America
1
2021
312
0.160
 Why?
Argentina
1
2019
30
0.150
 Why?
Bone Diseases
1
2020
61
0.150
 Why?
Animals, Newborn
1
2002
890
0.150
 Why?
Walking
1
2024
542
0.150
 Why?
Mutation, Missense
1
2001
338
0.150
 Why?
Practice Guidelines as Topic
4
2020
1569
0.150
 Why?
Protein S Deficiency
2
1996
8
0.150
 Why?
Factor XIII
2
2024
15
0.150
 Why?
Magnetic Resonance Imaging
5
2017
3888
0.150
 Why?
Risk
4
2013
911
0.140
 Why?
International Cooperation
2
2013
197
0.140
 Why?
Aged, 80 and over
6
2018
8284
0.140
 Why?
Heart Defects, Congenital
2
2018
905
0.140
 Why?
Ketorolac
1
2018
30
0.140
 Why?
Antibodies
3
2013
396
0.140
 Why?
Predictive Value of Tests
2
2021
2117
0.130
 Why?
Platelet Adhesiveness
1
2017
14
0.130
 Why?
Enzyme-Linked Immunosorbent Assay
3
2014
835
0.130
 Why?
Hemorheology
1
2017
24
0.130
 Why?
Immune Tolerance
2
2015
381
0.130
 Why?
Herpesvirus 3, Human
1
2001
337
0.130
 Why?
Chondroitin Sulfates
1
2017
35
0.130
 Why?
Pediatrics
2
2024
1121
0.130
 Why?
Sensitivity and Specificity
5
2012
1995
0.130
 Why?
Observer Variation
4
2015
355
0.130
 Why?
Arthralgia
1
2017
61
0.130
 Why?
Electrocardiography
2
2018
664
0.130
 Why?
Office Visits
1
2017
92
0.120
 Why?
Secondary Prevention
2
2016
255
0.120
 Why?
Whole Genome Sequencing
1
2017
184
0.120
 Why?
Retrospective Studies
11
2020
17149
0.120
 Why?
Immunoglobulins
1
2016
160
0.120
 Why?
Medication Adherence
2
2017
540
0.120
 Why?
Area Under Curve
3
2011
329
0.120
 Why?
Fluorescent Antibody Technique
1
2016
364
0.110
 Why?
Risk Assessment
4
2011
3729
0.110
 Why?
Kinetics
3
2005
1602
0.110
 Why?
Fetal Proteins
1
1995
15
0.110
 Why?
Blood Coagulation Factor Inhibitors
1
2015
4
0.110
 Why?
Coagulation Protein Disorders
2
2008
3
0.110
 Why?
Cost of Illness
1
2017
322
0.110
 Why?
Residence Characteristics
1
2018
374
0.110
 Why?
Hemostasis, Surgical
2
2011
25
0.110
 Why?
Syndrome
2
2006
379
0.110
 Why?
Models, Biological
4
2024
1811
0.110
 Why?
Ankle Joint
2
2024
122
0.110
 Why?
Renal Veins
1
1994
18
0.100
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2014
103
0.100
 Why?
Pregnancy, Animal
1
1994
51
0.100
 Why?
Factor VIIIa
2
2006
4
0.100
 Why?
Muscle, Skeletal
1
2024
1788
0.100
 Why?
Chorioamnionitis
1
2014
49
0.100
 Why?
Contraceptives, Oral, Hormonal
2
2005
30
0.100
 Why?
Spectrum Analysis
2
2005
91
0.100
 Why?
Interleukin-8
1
2014
269
0.100
 Why?
Maternal-Fetal Exchange
1
1994
169
0.100
 Why?
Neoplasms
3
2024
2873
0.100
 Why?
Reference Values
2
2007
794
0.100
 Why?
Randomized Controlled Trials as Topic
2
2010
1742
0.100
 Why?
Fibrin Clot Lysis Time
1
2012
10
0.090
 Why?
Interleukin-1beta
1
2014
390
0.090
 Why?
Heparin, Low-Molecular-Weight
1
2012
36
0.090
 Why?
Hepatitis C
3
2013
254
0.090
 Why?
Migraine with Aura
1
2012
6
0.090
 Why?
Cardiac Surgical Procedures
1
2018
609
0.090
 Why?
Cytokines
3
2020
2045
0.090
 Why?
Quality Improvement
1
2021
1287
0.090
 Why?
Collagen Type I
1
2013
143
0.090
 Why?
Genetic Therapy
2
2005
313
0.090
 Why?
Abdomen
1
2013
141
0.090
 Why?
Polysaccharides
1
2012
86
0.090
 Why?
Canada
2
2003
432
0.090
 Why?
Preoperative Care
2
2011
379
0.090
 Why?
Enoxaparin
1
2012
68
0.090
 Why?
Fatal Outcome
1
2012
305
0.090
 Why?
Nervous System Diseases
1
2014
285
0.090
 Why?
Immunomodulation
1
2012
98
0.080
 Why?
Cerebrovascular Disorders
1
2012
106
0.080
 Why?
Edema
1
2012
124
0.080
 Why?
Research
1
2014
431
0.080
 Why?
Heart Diseases
1
2014
341
0.080
 Why?
Dose-Response Relationship, Drug
3
2016
2019
0.080
 Why?
International Classification of Diseases
1
2011
147
0.080
 Why?
Dependovirus
1
2011
77
0.080
 Why?
Hyperglycemia
1
1994
374
0.080
 Why?
Polymorphism, Genetic
1
2013
613
0.080
 Why?
Myocardial Infarction
1
2018
1209
0.080
 Why?
Interleukin-6
1
2014
770
0.080
 Why?
Phlebography
2
2008
41
0.080
 Why?
Heterozygote
2
2008
313
0.080
 Why?
Arm
1
2010
110
0.080
 Why?
Pharmacokinetics
1
2009
32
0.080
 Why?
Italy
1
2009
114
0.070
 Why?
Moyamoya Disease
1
2009
20
0.070
 Why?
Family Health
1
2010
191
0.070
 Why?
Hepatitis B
3
2013
65
0.070
 Why?
Drug Therapy, Combination
3
2016
1044
0.070
 Why?
Postoperative Care
1
2011
286
0.070
 Why?
Leg
1
2011
240
0.070
 Why?
Lower Extremity
1
2013
440
0.070
 Why?
Recombination, Genetic
1
2010
205
0.070
 Why?
Animals
8
2025
37948
0.070
 Why?
Blindness
1
2008
51
0.070
 Why?
Transcriptome
1
2015
1036
0.070
 Why?
Genotype
1
2013
1847
0.070
 Why?
Inflammation
3
2014
2870
0.070
 Why?
Thromboplastin
2
2013
64
0.070
 Why?
Smoking
1
2015
1467
0.070
 Why?
Cysteine Endopeptidases
2
2013
69
0.070
 Why?
Forecasting
1
2010
391
0.070
 Why?
Research Design
2
2015
1129
0.070
 Why?
Genetic Predisposition to Disease
4
2013
2350
0.070
 Why?
Combined Modality Therapy
1
2011
1268
0.070
 Why?
Antithrombin III
3
1994
18
0.060
 Why?
Overweight
1
2012
606
0.060
 Why?
Infant, Newborn, Diseases
1
2008
113
0.060
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2009
259
0.060
 Why?
Antibodies, Viral
1
2011
672
0.060
 Why?
Consensus
2
2024
475
0.060
 Why?
United States Food and Drug Administration
1
2008
205
0.060
 Why?
Health Surveys
2
2012
517
0.060
 Why?
Biomechanical Phenomena
2
2024
852
0.060
 Why?
Acute Disease
3
2012
1029
0.060
 Why?
Hypertension
1
2015
1262
0.060
 Why?
History, 20th Century
1
2008
327
0.060
 Why?
Kaplan-Meier Estimate
2
2022
967
0.060
 Why?
Logistic Models
4
2015
2114
0.060
 Why?
Regional Medical Programs
1
2006
6
0.060
 Why?
Blood Coagulation Disorders, Inherited
1
2006
4
0.060
 Why?
Data Collection
2
2016
635
0.060
 Why?
Age Distribution
3
2015
402
0.060
 Why?
Elbow Joint
1
2007
73
0.060
 Why?
Health Status Indicators
1
2007
167
0.060
 Why?
Ultrasonography
4
2000
776
0.060
 Why?
Fusobacterium necrophorum
1
2005
2
0.060
 Why?
Fusobacterium Infections
1
2005
7
0.060
 Why?
Computer Simulation
2
2024
1021
0.060
 Why?
Pharyngitis
1
2005
25
0.060
 Why?
Proportional Hazards Models
2
2020
1322
0.050
 Why?
Neuropsychological Tests
1
2010
1134
0.050
 Why?
Glycoproteins
3
1991
353
0.050
 Why?
DNA Mutational Analysis
2
2005
409
0.050
 Why?
Chronic Disease
1
2010
1810
0.050
 Why?
International Normalized Ratio
1
2004
52
0.050
 Why?
Regional Blood Flow
2
2017
513
0.050
 Why?
Muscle Tonus
1
2003
24
0.050
 Why?
Insulin
1
1994
2502
0.050
 Why?
Carboxypeptidase B2
1
2003
1
0.050
 Why?
Serum Globulins
1
2003
5
0.050
 Why?
Remission Induction
1
2004
309
0.050
 Why?
Radiography, Interventional
1
2024
128
0.050
 Why?
Phosphorus Radioisotopes
1
2002
25
0.050
 Why?
Guatemala
1
2024
344
0.050
 Why?
Delivery, Obstetric
1
2024
161
0.050
 Why?
Plasminogen Activator Inhibitor 1
1
2003
85
0.050
 Why?
Liver Diseases
1
2006
304
0.050
 Why?
Automation
1
2003
104
0.050
 Why?
Radionuclide Imaging
1
2002
115
0.050
 Why?
Elbow
1
2002
56
0.050
 Why?
Sex Factors
3
2013
2104
0.050
 Why?
Blood Sedimentation
1
2022
37
0.050
 Why?
Transfusion Reaction
1
2002
61
0.040
 Why?
Acceleration
1
2022
32
0.040
 Why?
Therapeutics
1
2022
14
0.040
 Why?
Knee
1
2002
71
0.040
 Why?
Ankle
1
2002
63
0.040
 Why?
Drug Costs
1
2003
117
0.040
 Why?
Obesity
2
2013
3070
0.040
 Why?
Injections
1
2002
197
0.040
 Why?
Liver Failure, Acute
1
2002
67
0.040
 Why?
Factor X
1
2001
25
0.040
 Why?
Algorithms
2
2011
1844
0.040
 Why?
Hormone Replacement Therapy
1
2002
107
0.040
 Why?
Clinical Laboratory Techniques
1
2002
96
0.040
 Why?
Pregnancy Outcome
1
2005
479
0.040
 Why?
Quality Assurance, Health Care
2
2015
341
0.040
 Why?
Body Weight
1
2006
968
0.040
 Why?
Phosphatidylserines
1
2001
60
0.040
 Why?
Developing Countries
1
2003
317
0.040
 Why?
Diagnostic Imaging
2
2015
341
0.040
 Why?
Hospitalization
1
2011
2446
0.040
 Why?
RNA, Messenger
2
2002
2815
0.040
 Why?
Polymorphism, Single Nucleotide
1
2008
2137
0.040
 Why?
Diagnostic Equipment
1
2000
5
0.040
 Why?
Exercise Therapy
1
2006
475
0.040
 Why?
Diagnosis, Differential
2
2017
1501
0.040
 Why?
Phosphatidylcholines
1
2001
130
0.040
 Why?
Self Care
1
2003
389
0.040
 Why?
Priapism
1
2000
10
0.040
 Why?
Evaluation Studies as Topic
1
2000
164
0.040
 Why?
Statistics as Topic
1
2001
284
0.040
 Why?
Purpura
2
1990
18
0.040
 Why?
False Negative Reactions
1
2000
61
0.040
 Why?
Drug Eruptions
1
2000
28
0.040
 Why?
Vitamin K
2
1999
45
0.040
 Why?
Cardiovascular Diseases
1
2012
2172
0.040
 Why?
Longitudinal Studies
2
2007
2942
0.040
 Why?
Veins
1
2000
69
0.040
 Why?
Quality Control
1
2000
164
0.040
 Why?
Prothrombin Time
1
1999
33
0.040
 Why?
Plethysmography
1
2000
104
0.040
 Why?
HIV Seronegativity
1
1999
29
0.040
 Why?
Gene Expression Regulation, Developmental
1
2005
906
0.040
 Why?
Vasoconstrictor Agents
1
2020
144
0.040
 Why?
False Positive Reactions
1
1999
122
0.040
 Why?
Cost-Benefit Analysis
1
2002
638
0.040
 Why?
Liposomes
1
2001
256
0.040
 Why?
Sheep Diseases
1
1999
9
0.040
 Why?
Comorbidity
2
2015
1652
0.040
 Why?
Disease Progression
1
2007
2847
0.040
 Why?
Motor Activity
1
2003
723
0.030
 Why?
Mitochondria
1
2025
984
0.030
 Why?
Age of Onset
2
2010
551
0.030
 Why?
ROC Curve
1
2020
618
0.030
 Why?
Time-to-Treatment
1
2020
242
0.030
 Why?
Therapeutic Equivalency
1
2018
31
0.030
 Why?
Mice, Knockout
1
2025
3109
0.030
 Why?
Asia
1
2018
71
0.030
 Why?
Disease Models, Animal
1
2008
4539
0.030
 Why?
Deamino Arginine Vasopressin
1
2017
13
0.030
 Why?
Factor VII
2
2013
24
0.030
 Why?
Intensive Care Units, Pediatric
1
2020
288
0.030
 Why?
Bone and Bones
1
2020
317
0.030
 Why?
Postoperative Period
1
2018
351
0.030
 Why?
Chromosome Disorders
1
1997
45
0.030
 Why?
Drug Resistance
1
1997
145
0.030
 Why?
Chromosome Aberrations
1
1997
164
0.030
 Why?
Pedigree
2
1996
515
0.030
 Why?
Arginine
1
1997
238
0.030
 Why?
Comparative Genomic Hybridization
1
2016
28
0.030
 Why?
Blood Flow Velocity
1
2017
419
0.030
 Why?
Models, Theoretical
1
2019
578
0.030
 Why?
Injections, Subcutaneous
1
2016
168
0.030
 Why?
Erythrocytes
1
2022
750
0.030
 Why?
Patient-Centered Care
1
2021
545
0.030
 Why?
Odds Ratio
2
2013
1076
0.030
 Why?
Plasmapheresis
1
2015
24
0.030
 Why?
Streptococcus pyogenes
1
1996
41
0.030
 Why?
Intracranial Embolism and Thrombosis
1
1995
7
0.030
 Why?
Decision Making
1
2003
973
0.030
 Why?
Stress, Mechanical
1
2017
494
0.030
 Why?
Models, Immunological
1
2015
100
0.030
 Why?
Cross-Over Studies
1
2018
605
0.030
 Why?
Florida
1
2015
117
0.030
 Why?
Embryonic and Fetal Development
1
1995
93
0.030
 Why?
Respiration, Artificial
1
2020
710
0.030
 Why?
Endpoint Determination
1
2015
84
0.030
 Why?
Causality
1
2015
126
0.030
 Why?
Parents
1
2003
1395
0.030
 Why?
Single-Blind Method
1
2015
319
0.030
 Why?
Sex Distribution
1
2015
386
0.030
 Why?
Neuroimaging
1
2016
293
0.030
 Why?
Polymerase Chain Reaction
1
1997
1047
0.030
 Why?
Factor VIIa
1
2013
43
0.020
 Why?
Propensity Score
1
2015
373
0.020
 Why?
Streptococcal Infections
1
1996
170
0.020
 Why?
Public Health Surveillance
1
2013
83
0.020
 Why?
Microfluidics
1
2013
62
0.020
 Why?
Gestational Age
2
2014
980
0.020
 Why?
Mice
2
2025
18261
0.020
 Why?
Sequence Analysis, DNA
1
2016
828
0.020
 Why?
Vena Cava, Inferior
1
2013
81
0.020
 Why?
Immunoglobulin G
1
2016
886
0.020
 Why?
Heparin Cofactor II
1
1991
1
0.020
 Why?
Horses
1
2013
203
0.020
 Why?
Chi-Square Distribution
1
2013
524
0.020
 Why?
Parvoviridae Infections
1
2011
12
0.020
 Why?
Homozygote
3
2003
200
0.020
 Why?
Cardiology
1
2014
359
0.020
 Why?
Protein Deficiency
1
1990
4
0.020
 Why?
Seroepidemiologic Studies
1
2011
171
0.020
 Why?
Feasibility Studies
1
2015
1103
0.020
 Why?
Immunosuppressive Agents
1
2015
834
0.020
 Why?
Complement Inactivator Proteins
1
1990
39
0.020
 Why?
Genetic Variation
1
2016
985
0.020
 Why?
Carrier Proteins
2
1991
733
0.020
 Why?
Liver
2
1999
1889
0.020
 Why?
Health Status Disparities
1
2013
318
0.020
 Why?
Delphi Technique
1
2011
330
0.020
 Why?
Genetic Vectors
1
2011
334
0.020
 Why?
Perioperative Care
1
2012
231
0.020
 Why?
Pilot Projects
1
2015
1886
0.020
 Why?
Molecular Weight
1
1989
312
0.020
 Why?
Multivariate Analysis
1
2013
1537
0.020
 Why?
Glucose
1
1994
1033
0.020
 Why?
Germany
1
2009
138
0.020
 Why?
Recovery of Function
1
2013
715
0.020
 Why?
Multicenter Studies as Topic
1
2009
408
0.020
 Why?
C-Reactive Protein
1
2009
420
0.020
 Why?
Twins
1
1988
152
0.020
 Why?
Vitamin K Deficiency
1
1986
9
0.020
 Why?
Evidence-Based Medicine
1
2010
732
0.020
 Why?
Polycystic Kidney Diseases
1
1987
71
0.010
 Why?
Kidney
1
1994
1495
0.010
 Why?
Protein Precursors
1
1986
136
0.010
 Why?
Endopeptidases
1
1986
79
0.010
 Why?
Cell Line
1
2011
2821
0.010
 Why?
Global Health
1
2008
401
0.010
 Why?
Postoperative Complications
1
1997
2950
0.010
 Why?
Wounds and Injuries
1
2013
960
0.010
 Why?
Body Mass Index
1
2013
2419
0.010
 Why?
Aging
1
1995
1938
0.010
 Why?
Introns
1
2005
255
0.010
 Why?
Exons
1
2005
362
0.010
 Why?
Antibody Formation
1
2005
291
0.010
 Why?
HIV Infections
2
2013
3148
0.010
 Why?
Abortion, Habitual
1
2002
4
0.010
 Why?
Arterial Occlusive Diseases
1
2003
90
0.010
 Why?
Acquired Immunodeficiency Syndrome
1
2001
235
0.010
 Why?
Necrosis
1
2000
243
0.010
 Why?
Factor X Deficiency
1
1999
3
0.010
 Why?
Counterimmunoelectrophoresis
1
1999
3
0.010
 Why?
Thrombin Time
1
1999
11
0.010
 Why?
Genes, Recessive
1
1999
78
0.010
 Why?
Immunoelectrophoresis, Two-Dimensional
2
1990
4
0.010
 Why?
Blotting, Western
1
2000
1161
0.010
 Why?
Base Sequence
1
2000
2177
0.010
 Why?
Molecular Sequence Data
1
2000
2909
0.010
 Why?
Urography
1
1987
19
0.000
 Why?
Genes, Dominant
1
1987
100
0.000
 Why?
Infant, Small for Gestational Age
1
1986
111
0.000
 Why?
Serine Endopeptidases
1
1986
129
0.000
 Why?
Protein Binding
1
1986
2243
0.000
 Why?
Manco-Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (497) concept(s)
_
Co-Authors Expand Description
See all (40) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)